
Abiomed ABMD
Quarterly report 2022-Q3
added 11-03-2022
Abiomed Operating Expenses 2011-2026 | ABMD
Annual Operating Expenses Abiomed
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 456 M | 440 M | 415 M | 338 M | 285 M | 214 M | 162 M | 138 M | 110 M | 100 M | 90.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 456 M | 90.4 M | 250 M |
Quarterly Operating Expenses Abiomed
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 132 M | 119 M | 110 M | 94.8 M | 109 M | 111 M | 110 M | 110 M | 107 M | 104 M | 102 M | 102 M | 96.8 M | 84.3 M | 79.5 M | 77.5 M | 76.4 M | 70.3 M | 71.1 M | 66.7 M | 59.5 M | 55.6 M | 51.4 M | 47.5 M | 44.4 M | 38.5 M | 38.1 M | 40.7 M | 36.6 M | 32.1 M | 33.9 M | 35.3 M | 30.7 M | 27.2 M | 24.3 M | 27.8 M | 27.6 M | 23.7 M | 23.2 M | 25.9 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 132 M | 23.2 M | 66.5 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
2.19 B | $ 184.69 | 2.23 % | $ 13.8 B | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
AxoGen
AXGN
|
121 M | $ 34.46 | 2.96 % | $ 1.59 B | ||
|
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
59.6 M | $ 12.77 | 3.65 % | $ 1.73 B | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
1.03 B | $ 292.23 | 1.41 % | $ 8.24 B | ||
|
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.59 | 0.67 % | $ 36.7 M | ||
|
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.37 | 1.35 % | $ 126 M | ||
|
Bruker Corporation
BRKR
|
1.4 B | $ 39.9 | 2.18 % | $ 5.94 K | ||
|
Boston Scientific Corporation
BSX
|
10.2 B | $ 63.82 | 1.01 % | $ 94.5 B | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
Inogen
INGN
|
184 M | $ 6.34 | -1.71 % | $ 169 M | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.03 | - | $ 17.4 M | ||
|
ClearPoint Neuro
CLPT
|
15.3 M | $ 10.38 | 3.7 % | $ 294 M | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
40.3 M | $ 25.21 | 1.47 % | $ 213 M | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
LENSAR
LNSR
|
32.6 M | $ 6.04 | 2.03 % | $ 72.2 M | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
547 M | $ 94.94 | 2.11 % | $ 12.8 B | ||
|
Helius Medical Technologies
HSDT
|
12.5 M | $ 1.98 | -2.46 % | $ 1.2 M | ||
|
Butterfly Network
BFLY
|
123 M | $ 4.44 | 3.74 % | $ 940 M | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
Myomo
MYO
|
41.3 M | $ 0.79 | 8.49 % | $ 33.1 M | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
OrthoPediatrics Corp.
KIDS
|
212 M | $ 17.86 | 5.37 % | $ 419 M | ||
|
Delcath Systems
DCTH
|
72.8 M | $ 10.88 | 4.11 % | $ 390 M | ||
|
Inspire Medical Systems
INSP
|
240 M | $ 56.83 | 3.48 % | $ 1.67 B | ||
|
CONMED Corporation
CNMD
|
648 M | $ 39.73 | 3.3 % | $ 1.23 B | ||
|
LivaNova PLC
LIVN
|
697 M | $ 64.99 | 0.63 % | $ 3.55 B | ||
|
Integer Holdings Corporation
ITGR
|
279 M | $ 88.63 | 1.03 % | $ 3.08 B | ||
|
FONAR Corporation
FONR
|
28.7 M | $ 18.76 | 0.27 % | $ 123 M | ||
|
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 78.2 | 0.1 % | $ 45.7 B |